Effect of yoga as add-on therapy in migraine (CONTAIN) A randomized clinical trial

被引:29
|
作者
Kumar, Anand [1 ]
Bhatia, Rohit [1 ]
Sharma, Gautam [2 ,6 ]
Dhanlika, Dhanlika [3 ]
Vishnubhatla, Sreenivas [4 ]
Singh, Rajesh Kumar [5 ]
Dash, Deepa [5 ]
Tripathi, Manjari [5 ]
Srivastava, M. V. Padma [5 ]
机构
[1] All India Inst Med Sci, Dept Neurol, New Delhi, India
[2] All India Inst Med Sci, Dept Cardiol, New Delhi, India
[3] All India Inst Med Sci, Ctr Integrated Med & Res CIMR, New Delhi, India
[4] All India Inst Med Sci, Dept Biostat, New Delhi, India
[5] All India Inst Med Sci, New Delhi, India
[6] Cardiothorac Ctr, New Delhi, India
关键词
HEADACHES; IMPACT;
D O I
10.1212/WNL.0000000000009473
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective To evaluate the effectiveness of yoga as an adjuvant to conventional medical management on clinical outcomes in patients with migraine. Methods CONTAIN was a prospective, randomized, open-label superiority trial with blinded endpoint assessment carried out at a single tertiary care academic hospital in New Delhi, India. Patients enrolled were aged 18-50 years with a diagnosis of episodic migraine and were randomized into medical and yoga groups (1:1). Randomization was computer-generated with a variable block size and concealed. A predesigned yoga intervention was given for 3 months. Outcomes were recorded by a blinded assessor. The primary endpoint was a decrease in headache frequency, headache intensity, and Headache Impact Test (HIT)-6 score. Secondary outcomes included change in Migraine Disability Assessment (MIDAS) score, pill count, and proportion of headache free patients. Results Between April 2017 and August 2018, 160 patients with episodic migraine were randomly assigned to medical and yoga groups. A total of 114 patients completed the trial. Baseline measures were comparable except for a higher mean headache frequency in the yoga group. Compared to medical therapy, the yoga group showed a significant mean delta value reduction in headache frequency (delta difference 3.53 [95% confidence interval 2.52-4.54];p< 0.0001), headache intensity (1.31 [0.60-2.01];p= 0.0004), HIT score (8.0 [4.78-11.22];p< 0.0001), MIDAS score (7.85 [4.98-10.97];p< 0.0001), and pill count (2.28 [1.06-3.51];p< 0.0003). Conclusion Yoga as an add-on therapy in migraine is superior to medical therapy alone. It may be useful to integrate a cost-effective and safe intervention like yoga into the management of migraine. Clinicaltrials.gov identifier CTRI/2017/03/008041. Classification of evidence This study provides Class III evidence that for patients with episodic migraine, yoga as adjuvant to medical therapy improves headache frequency, intensity, impact, and disability.
引用
收藏
页码:E2203 / E2212
页数:10
相关论文
共 50 条
  • [31] Effect of add-on acarbose to insulin therapy in routine clinical practice
    Klocke, KR
    Stauch, K
    Landen, H
    CLINICAL DRUG INVESTIGATION, 2003, 23 (10) : 621 - 627
  • [32] Effect of Add-On Acarbose to Insulin Therapy in Routine Clinical Practice
    K. R. Klocke
    K. Stauch
    H. Landen
    Clinical Drug Investigation, 2003, 23 : 621 - 627
  • [33] Clinical experience with Pregabalin add-on therapy
    Meencke, HJ
    Dehnicke, C
    Merschhemke, M
    Meinken-Jaeggi, D
    EPILEPSIA, 2005, 46 : 180 - 180
  • [34] Add-on Topiramate for the Pharmacological Management of Schizophrenia: A Double Blind Randomized Clinical Trial
    Mousavi, Seyed Ghafur
    Golchin, Sharareh
    Afshar, Hamid
    Afza, Hamid Reza Rooh
    IRANIAN JOURNAL OF PSYCHIATRY AND BEHAVIORAL SCIENCES, 2007, 1 (02) : 16 - 22
  • [35] Computerized Cognitive Training for ADHD as an Add-On Treatment to Stimulants: A Randomized Clinical Trial
    de Oliveira Rosa, Virginia
    Moreira-Maia, Carlos Renato
    Wagner, Flavia
    Simioni, Andre
    de Fraga Bassotto, Caroline
    Moritz, Guilherme R.
    Schmitz, Marcelo
    Rohde, Luis Augusto Paim
    JOURNAL OF ATTENTION DISORDERS, 2021, 25 (02) : 275 - 285
  • [36] Effect of yoga as an add-on therapy in the modulation of heart rate variability in children with duchenne muscular dystrophy
    Pradnya, Dhargave
    Nalini, Atchayaram
    Nagarathna, Raghuram
    Raju, Trichur R.
    Sendhilkumar, Ragupathy
    Meghana, Adoor
    Sathyaprabha, Talakad N.
    INTERNATIONAL JOURNAL OF YOGA, 2019, 12 (01) : 55 - 61
  • [37] Add-on probiotics in patients with persistent allergic rhinitis: A randomized crossover clinical trial
    Jalali, Mir Mohammad
    Soleimani, Robabeh
    Foumani, Ali Alavi
    Khosravi, Hooman Ganjeh
    LARYNGOSCOPE, 2019, 129 (08): : 1744 - 1750
  • [38] Safety and Efficacy of Nanocurcumin as Add-On Therapy to Riluzole in Patients With Amyotrophic Lateral Sclerosis: A Pilot Randomized Clinical Trial
    Ahmadi, Mona
    Agah, Elmira
    Nafissi, Shahriar
    Jaafari, Mahmoud Reza
    Harirchian, Mohammad Hossein
    Sarraf, Payam
    Faghihi-Kashani, Sara
    Hosseini, Seyed Jalal
    Ghoreishi, Abdolreza
    Aghamollaii, Vajiheh
    Hosseini, Mostafa
    Tafakhori, Abbas
    NEUROTHERAPEUTICS, 2018, 15 (02) : 430 - 438
  • [39] Achillea millefolium is beneficial as an add-on therapy in patients with multiple sclerosis: A randomized placebo-controlled clinical trial
    Ayoobi, Fatemeh
    Moghadam-Ahmadi, Amir
    Amiri, Houshang
    Vakilian, Alireza
    Heidari, Moslem
    Farahmand, Habib
    Fathollahi, Mahmood Sheikh
    Fatemi, Imam
    Shafiei, Seyed Ali
    Alahtavakoli, Mohammad
    Shamsizadeh, Ali
    PHYTOMEDICINE, 2019, 52 : 89 - 97
  • [40] Safety and Efficacy of Nanocurcumin as Add-On Therapy to Riluzole in Patients With Amyotrophic Lateral Sclerosis: A Pilot Randomized Clinical Trial
    Mona Ahmadi
    Elmira Agah
    Shahriar Nafissi
    Mahmoud Reza Jaafari
    Mohammad Hossein Harirchian
    Payam Sarraf
    Sara Faghihi-Kashani
    Seyed Jalal Hosseini
    Abdolreza Ghoreishi
    Vajiheh Aghamollaii
    Mostafa Hosseini
    Abbas Tafakhori
    Neurotherapeutics, 2018, 15 : 430 - 438